{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:40:32Z","timestamp":1771530032528,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Proto-oncogene-oriented targeted therapy has limited benefits in elderly patients with multiple primary tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A woman with anaplastic lymphoma kinase-positive lung adenocarcinoma developed acquired resistance after 3 years of targeted therapy with crizotinib.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Diagnosis of unexpected subsequent primary gallbladder tumor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Lenvatinib was administered therapeutically. Meanwhile, next-generation sequencing results before and after crizotinib treatment were analyzed by comparing the tumor-driving mutation genes with bioinformatics methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient died of ascites and liver failure. Furthermore, bypass activation was found to be the main reason for acquired drug resistance for this patient, and the abnormal expression of tumor suppressor genes and senescence-related genes was the likely cause of the second primary tumor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>A bioinformatic comparison of pre- and post-treatment sequencing in elderly oncology patients is of interest.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>For diagnosing, precision bioinformatics analysis and repeat biopsy are equally valuable. For therapy, potential therapy such as p53 gene replacement therapy and CAR-T therapy need to be practiced for senescence-related conditions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033162","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:02:17Z","timestamp":1679068937000},"page":"e33162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Acquired crizotinib-resistant pulmonary adenocarcinoma and subsequent primary gallbladder cancer: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Zhejiang Chinese Medicine University, HangZhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruilin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-5219","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.201708092","article-title":"Senescence and aging: causes, consequences, and therapeutic avenues.","volume":"217","author":"McHugh","year":"2018","journal-title":"J Cell Biol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature14336","article-title":"Therapy-induced tumour secretomes promote resistance and tumour progression.","volume":"520","author":"Obenauf","year":"2015","journal-title":"Nature"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e596","DOI":"10.1097\/MD.0000000000000596","article-title":"Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.","volume":"94","author":"Mao","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"W114","DOI":"10.1093\/nar\/gky407","article-title":"GWAS4D: multidimensional analysis of context-specific regulatory variant for human complex diseases and traits.","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants.","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nprot.2013.092","article-title":"Large-scale gene function analysis with the PANTHER classification system.","volume":"8","author":"Mi","year":"2013","journal-title":"Nat Protoc"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.","volume":"8","author":"Gy\u0151rffy","year":"2013","journal-title":"PLoS One"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"D1023","DOI":"10.1093\/nar\/gkv1268","article-title":"TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.","volume":"44","author":"Zhao","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R11-20250504","first-page":"259","article-title":"Mutagenesis at methylated CpG sequences.","volume":"301","author":"Pfeifer","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"D825","DOI":"10.1093\/nar\/gkaa894","article-title":"Aging atlas: a multi-omics database for aging biology.","volume":"49","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-14-1511","article-title":"Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.","volume":"20","author":"Katayama","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"377377","DOI":"10.21037\/atm.2017.07.18","article-title":"Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance.","volume":"5","author":"Attarian","year":"2017","journal-title":"Ann Transl Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1158\/1078-0432.CCR-19-1176","article-title":"Acquired resistance mutations to ALK inhibitors identified by single circulating tumor cell sequencing in ALK-rearranged non-small-cell lung cancer.","volume":"25","author":"Pailler","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"Suppl 3","key":"R16-20250504","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1093\/annonc\/mdw305","article-title":"Crizotinib resistance: implications for therapeutic strategies.","volume":"27","author":"Dagogo-Jack","year":"2016","journal-title":"Ann Oncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.21037\/tlcr-20-372","article-title":"Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won.","volume":"9","author":"Tabb\u00f2","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer.","volume":"6","author":"Gainor","year":"2016","journal-title":"Cancer Discov"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lungcan.2016.10.012","article-title":"Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: a new mechanism of resistance to ALK inhibitors.","volume":"102","author":"Levacq","year":"2016","journal-title":"Lung Cancer"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.2147\/OTT.S139718","article-title":"Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report.","volume":"10","author":"Zhu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R21-20250504","first-page":"398","article-title":"Gallbladder metastasis of non-small cell lung cancer.","volume":"27","author":"Nassenstein","year":"2004","journal-title":"Onkologie"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0300891620933678","article-title":"Multiple primary malignancies involving lung cancer: a single-center experience.","volume":"107","author":"Ventura","year":"2021","journal-title":"Tumori"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3389\/fonc.2020.01251","article-title":"Catalog of lung cancer gene mutations among chinese patients.","volume":"10","author":"Xue","year":"2020","journal-title":"Front Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cell.2005.02.003","article-title":"Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.","volume":"120","author":"Campisi","year":"2005","journal-title":"Cell"},{"key":"R26-20250504","first-page":"659","article-title":"An unusual case report: occurrence of renal cell carcinoma, basal cell carcinoma and chronic lymphocytic leukemia in a case of papillary thyroid carcinoma treated with radioactive iodine.","volume":"43","author":"Dehghani","year":"2018","journal-title":"Iran J Med Sci"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies.","volume":"11","author":"Walcher","year":"2020","journal-title":"Front Immunol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/carcin\/bgaa071","article-title":"Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.","volume":"41","author":"Beck","year":"2020","journal-title":"Carcinogenesis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.1038\/s41598-020-69145-1","article-title":"Author correction: germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer.","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies.","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:11:24Z","timestamp":1746328284000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033162","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}